Strategies for perioperative chemotherapy are established on the basis of the subtypes of BC, namely, hormone receptor (HR)-positive [estrogen receptor (ER) and/or progesterone receptor-positive], human epidermal growth factor receptor 2 (HER2)-positive, and triple-negative. Here, ERBB2 is linked to breast cancer.